A Retrospective Study of Early Postoperative Mobilization in the Recovery of Patients With Oral Head and Neck Tumors Who Underwent Flap Reconstruction

May 1, 2023 updated by: Jie He, MD
All patients with head and neck cancers and osteomyelitis who underwent vascularized flap reconstruction at Shanghai Ninth People's Hospital (North Campus), Shanghai Jiao Tong University, from February 2020 to July 2021 were the object of a retrospective data collection.Depending on whether they had postoperative early mobilization, all patients were split into experimental and control groups.In the experimental group, patients were split into two groups based on the postoperative day(POD): the POD 0-1 group and the POD >1 group.Comparison and analysis were done on the difference in hospital days and post-operative complication rates between the two groups.

Study Overview

Status

Completed

Intervention / Treatment

Study Type

Observational

Enrollment (Actual)

244

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

    • Shanghai
      • Shanghai, Shanghai, China, 200000
        • Shanghai Ninth People's Hospital

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

  • Child
  • Adult
  • Older Adult

Accepts Healthy Volunteers

No

Sampling Method

Non-Probability Sample

Study Population

Early Mobilizationon Recovery After Major Head and Neck Surgery With Flap Reconstruction

Description

Inclusion Criteria:

  1. Patients with head and neck diseases undergoing flap reconstruction and repair
  2. Patients with complete data preservation and consent
  3. Patients who follow medical advice during hospitalization

Exclusion Criteria:

  1. Patients who survived less than 1 month after surgery
  2. Patients with other tumors before surgery 3, mental patients, audio-visual impairment or uncooperative patients

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

Cohorts and Interventions

Group / Cohort
Intervention / Treatment
Early MobilizatioN
The time the patient began to sit, stand, and walk after surgery is earlier than traditional model.
conventional Mobilization

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Length of hospital stay after surgery
Time Frame: February 2020 to July 2021
The time span between the end of surgery and hospital discharge is defined as the length of hospital stay after surgery.
February 2020 to July 2021

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
pulmonary infection rate
Time Frame: February 2020 to July 2021
The pulmonary infection rate is calculated as the proportion of hospitalized patients who had pulmonary infections over all patients.
February 2020 to July 2021
deep vein thrombosis rate
Time Frame: February 2020 to July 2021
The deep vein thrombosis rate is calculated as the proportion of hospitalized patients who had deep vein thrombosis over all patients.
February 2020 to July 2021
flap crisis rate
Time Frame: February 2020 to July 2021
The flap crisis rate is calculated as the proportion of hospitalized patients who had flap crisis over all patients.
February 2020 to July 2021

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Sponsor

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

March 1, 2020

Primary Completion (Actual)

July 31, 2021

Study Completion (Actual)

August 1, 2021

Study Registration Dates

First Submitted

May 1, 2023

First Submitted That Met QC Criteria

May 1, 2023

First Posted (Actual)

May 10, 2023

Study Record Updates

Last Update Posted (Actual)

May 10, 2023

Last Update Submitted That Met QC Criteria

May 1, 2023

Last Verified

May 1, 2023

More Information

Terms related to this study

Additional Relevant MeSH Terms

Other Study ID Numbers

  • 654321

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Length of Hospital Stay

Clinical Trials on Early Mobilization

Subscribe